171976-97-9

Upstream product

• 58111-84-5 Z-L-Ser-L-Tyr-N₃ 
• 55610-27-0 Z-L-Ser-L-Tyr-N₂H₃ 
• 171976-99-1 (R)-2-[(S)-2-((S)-2-Benzyloxycarbonylamino-3-hydroxy-propionylamino)-3-(4-hydroxy-phenyl)-propionylamino]-succinic acid 4-benzyl ester 

Downstream Products

• 171976-93-5 (R)-3-[(S)-2-((S)-2-Amino-3-hydroxy-propionylamino)-3-(4-hydroxy-phenyl)-propionylamino]-N-{(S)-1-[(S)-1-((S)-2-ethylcarbamoyl-pyrrolidine-1-carbonyl)-4-guanidino-butylcarbamoyl]-3-methyl-butyl}-succinamic acid 
• 171976-98-0 C₄₅H₇₁N₁₁O₁₃ 
• 171976-95-7 (R)-N-{(S)-1-[(S)-1-((S)-2-Ethylcarbamoyl-pyrrolidine-1-carbonyl)-4-guanidino-butylcarbamoyl]-3-methyl-butyl}-3-((S)-3-(4-hydroxy-phenyl)-2-{(S)-3-hydroxy-2-[((S)-pyrrolidine-2-carbonyl)-amino]-propionylamino}-propionylamino)-succinamic acid 

Relevant academic research and scientific papers

SYNTHESIS AND INVESTIGATION OF THE ANTITUMORAL ACTIVITY OF SHORTENED ANALOGS OF LULIBERIN

With the aim of obtaining antitumoral drugs possessing a binary action mechanism, we have synthesized a series of shortened analogs of luliberin, including some containing a 1-carboxymethyl-5-fluorouracil residue.Their antitumoral and hormonal activities